Your shopping cart is currently empty

ADR-925, an active chelated iron metabolite of dexrazoxane, has the ability to protect neonatal rat cardiomyocytes from doxorubicin-induced injury.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $1,120 | - | In Stock | |
| 5 mg | $2,250 | - | In Stock | |
| 10 mg | $2,970 | - | In Stock | |
| 25 mg | $4,490 | - | In Stock | |
| 50 mg | $5,970 | - | In Stock |
| Description | ADR-925, an active chelated iron metabolite of dexrazoxane, has the ability to protect neonatal rat cardiomyocytes from doxorubicin-induced injury. |
| In vivo | METHODS: ADR-925 (ICRF 198) (88 mg/kg, intraperitoneal injection, 30 minutes before doxorubicin injection, once a week, 12 times) was administered to mice to observe the protective effect of ADR-925 against the lethal effects of mice. RESULTS In animals pretreated with ADR559, there was partial protection against the lethal effects of doxorubicin. [2] |
| Synonyms | ICRF-198, ICRF198, ICRF 198, ADR925, ADR 925 |
| Molecular Weight | 304.3 |
| Formula | C11H20N4O6 |
| Cas No. | 75459-34-6 |
| Smiles | N([C@H](CN(CC(N)=O)CC(O)=O)C)(CC(N)=O)CC(O)=O |
| Relative Density. | 1.409 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.